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Outbreaks of Salmonellosis remain a major public health problem globally.
This study determined the diversity and antibiotic resistance gene profile of Salmo-
nella enterica serovars isolated from humans and food animals. Using standard
methods, Salmonella spp. were isolated from fecal samples, profiled for antimicrobial
susceptibility and resistance genes. Seventy-one Salmonella isolates were recovered
from both humans and food animals comprising cattle, sheep, and chicken. Forty-four
serovars were identified, with dominant Salmonella Budapest (31.8%). Rare serovars
were present in chicken (S. Alfort, S. Wichita, S. Linton, S. Ealing, and S. Ebrie) and
humans (S. Mowanjum, S. Huettwillen, S. Limete, and S. Chagoua). Sixty-eight
percent of isolates were sensitive to all test antibiotics, while the highest rate of
resistance was to nalidixic acid (16.9%; n= 12), followed by ciprofloxacin (11.3%;
n= 8) and tetracycline (9.9%; n= 8). Five isolates (7%) were multidrug-resistant and
antimicrobial resistance genes coding resistance to tetracycline (tetA), beta-lactam
(blaTEM), and quinolone/fluoroquinolone (qnrB and qnrS) were detected. Evolutionary
analysis of gyrA gene sequences of human and food animal Salmonella isolates
revealed variations but are evolutionarily interconnected. Isolates were grouped into
four clades with S. Budapest isolate from cattle clustering with S. Budapest isolated
from chicken, whereas S. Essen isolated from sheep and chicken was grouped into a
clade. Diverse S. enterica serovars with high antibiotic resistance profile are
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ubiquitous in food animals; hence, there is a need for surveillance and prudent use of
antibiotics in human and veterinary medicine.
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Introduction
Salmonellosis continue to pose substantial health challenges in developed
and developing countries [1]. Over 2,500 Salmonella enterica serovars have been
identified and some of which are the etiology of salmonellosis that is presented
mainly as enteric fever in cases caused by Salmonella Typhi or Paratyphi and
gastroenteritis caused by other S. enterica serovars. While the former is most of the
time severe and invasive, the latter tends to be self-limiting; however, it could be
severe and systemic in infants, older people, and immunocompromised indivi-
duals [2–4]. Epidemiological surveillance overtime has revealed that outbreaks of
salmonellosis in human are linked to ingestion of foods mainly of animal origin
that are contaminated with Salmonella; thus, most Salmonella infections could be
considered as zoonotic. However, host-specific serovars like S. Typhi transmission
is often through the fecal–oral route and not considered to be zoonotic. Establish-
ing the route of transmission is more or less difficult, since the transmission chain
is complex [2, 5, 6]. Food animals (chicken, pork, cattle, sheep, and even fish) are
a major reservoir of diverse serovars of S. enterica as has been documented in
several reports [7–11]. This persistence of S. enterica in the intestinal tract of food
animals creates a chronic or non-symptomatic carrier state that provides for
continuous shedding of bacteria in feces, thereby serving as a reservoir for
subsequent spread by contaminated meat, milk, eggs, and agricultural products
cultivated on Salmonella-containing manure lands [12]. Not only food animals are
sources of Salmonella infections, they also serve as a channel for the dissemination
of multidrug-resistant (MDR) serovars, which in recent times has emerged as a
threat to the effective treatment of infections. In a 2014World Health Organization
(WHO) report on resistance of selected bacteria of international concern to
antibacterial drugs, non-typhoidal Salmonella (NTS) resistance to fluoroquino-
lones made the list with a total number of reports with data sets based on ≥30
tested isolates to be as high as 75% [13]. Resistance of Salmonella spp. to most
widely used classes of antibiotics spans from aminoglycosides, chloramphenicol,
tetracycline, beta-lactams (including cephalosporin), quinolones, sulfonamide and
trimethoprim to polymyxins [14–16]. In Nigeria, there has been reports of the
isolation and antibiotic resistance profiling of Salmonella serovars isolated
from humans, chicken, and pigs [17–19] but there is drought of information on
studies that evaluates human and a broader range of food animals at once.
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Hence, this study explores the diversity and antibiotic resistance genes profile of
Salmonella serovars isolated from humans and three major food animals in Lagos,
Nigeria, a cosmopolitan city in West Africa.
Materials and Methods
Study design
The study is composed of humans and food animals (cattle, sheep, and chicken).
Group 1: This group comprised human subjects who were apparently
healthy food handlers recruited based on the following criteria: (1) adults with
≥18 years of age (both male and female) and (2) not on any form of antibiotic
treatment. Sample size for human subject was defined as:
n=
Z2pq
d2
,
where:
Z→ Standard normal deviate= 1.96
p→ Prevalence≅ 0.304 according to Smith et al. [20]
q→ 1− p= 1− 0.304
d→ Tolerable margin of error= 0.05
n= n= ð1.96Þ
2 × ð0.304Þ× ð0.696Þ
ð0.5Þ20.0025 = 0.8128211
n= 325.1.
With a gazette 10% non-response rate
n= 325+ 33= 358.
Group 2: This comprised apparently healthy food animals (cattle, sheep, and
chicken) that were being processed for slaughter. One hundred and two fecal
samples were collected from each animal type making the total sample size
from animals to be 306. Therefore, the total number of samples collected for both
group was 664.
Sample collection
Fecal samples were collected from humans, cattle, sheep, and chicken
between June 2016 and March, 2017. Samples were collected from animals
randomly selected each day of sample collection. Fecal samples were obtained
after slaughter from viscera (intestine) in sterile specimen bottles appropriately
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labeled and transported in a thermobox at 4 °C to the laboratory immediately.
Fecal samples were also collected from humans in sterile sample bottles and
transported immediately to the laboratory under the same conditions earlier stated.
Isolation and identification of isolates
Five grams of each fecal sample were enriched in 25 ml of selenite F broth
(Oxoid, Basingstoke, UK) and incubated at 37 °C for 18–24 h. This was followed
by plating onto Salmonella–Shigella agar (Oxoid) and incubated at 37 °C for 24 h.
Presumptive colonies were further purified by subculturing on nutrient agar
(Oxoid). Pure colonies were identified using biochemical tests including
motility, indole, urease, mannitol, lysine decarboxylase, citrate, ortho-nitrophenyl-
β-galactoside, Kliger Iron Agar to determine H2S and gas production, lactose and
glucose fermentation, oxidase and catalase.
Serotyping
Serotyping of all biochemically confirmed Salmonella isolates was carried
out at Centre Nationale de Référence de Salmonella, Laboratoire de Bactériologie
et Virologie Institut Pasteur de Côte d’Ivoire according to White Kauffmann–Le
Minor scheme [21]. Serotyping was carried out by slide agglutination test to
characterize O and H antigens using commercially available antisera (Bio-Rad,
F-92430 Marnes-La-Coquette, France).
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed using the disk diffusion
method according to the European committee on antimicrobial susceptibility
testing [22] guidelines. Salmonella isolates were inoculated into brain–heart infusion
broth (Oxoid) and incubated at 37 °C for 18 h after which they were subcultured on
Mueller–Hinton agar (Hi-Media Laboratories Pvt. Ltd., India) at 37 °C for 24 h.
Two to three distinct colonies were emulsified in 5 ml of sterile physiological saline
and adjusted to 0.5McFarland standard and then a sterile swab stick was in applying
bacteria suspension to the surface of Mueller–Hinton agar. Antibiotic disks were
then applied comprising ampicillin (10 μg), ciprofloxacin (5 μg), tetracycline
(30 μg), minocycline (30 μg), colistin (50 μg), tobramycin (10 μg), nalidixic
acid (30 μg), norfloxacin (10 μg), imipenem (10 μg), cephalotin (30 μg),
ceftazidime (10 μg), gentamycin (10 μg), aztreonam (30 μg), ceftriaxone (30 μg),
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cefuroxime (30 μg), amikacin (30 μg), chloramphenicol (30 μg), cefotaxime (5 μg),
trimethoprim–sulfamethoxazole (25 μg), amoxicillin+clavulanic acid (30 μg), and
cefepime (30 μg) (Bio-Rad). The diameter of inhibition zone was measured
using ADAGIO (Bio-Rad) and was interpreted as resistance (R), intermidiate
(I), and sensitive (S). Escherichia coli ATCC 25922 was used as quality control
organism.
DNA extraction
Phenol–chloroform–isoamyl alcohol method of DNA extraction according
to Adi et al. [23] was adapted with modifications. Three to five colonies of
bacterial isolates grown on Colombia Blood Agar overnight was emulsified in
nuclease-free water to form a suspension. Cell suspension was refrigerated
at −20 °C for 15 min and then transferred to thermomixer held at 95 °C and
incubated for 15 min at 500 rpm and then centrifuged at 14,000 rpm for 10 min,
after which the supernatant containing the DNA was separated into a new sterile
Eppendorf tube. To the supernatant, 500 μl of phenol+ chloroform+ isoamyl
(25:24:1) was added, vortexed, and then centrifuged at 13,000 rpm for 10 min
at 4 °C. Eight hundred microliter of supernatant was obtained to which 80 μl of
sodium acetate+ 500 μl of absolute (100%) ethanol was added, vortexed gently,
and stored at −20 °C overnight. After centrifugation at 13,000 rpm for 20 min
at 4 °C, supernatant was discarded while 1 ml of ethanol (70%) was added to the
residue, vortexed gently, and then centrifuged at 13,000 rpm for 10 min at 4 °C;
then, supernatant was discarded; later, the residue was maintained at 70 °C to
allow the leftover ethanol to evaporate for 25–30 min. Then, it was reconstituted
with 60 μl of Elu Buf (NucliSENS, BioMerieux, France). Purity of DNA was
determined using a spectrophotometer and DNA was stored for further use
at −20 °C.
Detection of antibiotic resistance genes by polymerase chain reaction (PCR)
Nine antibiotic resistance genes (tetA, tetB, blaTEM, blaSHV, blaCTX-M, qnrA,
qnrB, qnrS, and gyrA) were assayed by PCR using primers listed in Table I.
A 50-μl PCR reaction was used that contained 28.8 μl of nuclease-free water,
3.5 μl MgCl2 (25 mM), 10 μl of 5× PCR buffer, 1 μl of dNTPs (10 mM), 0.75 μl of
each forward and reverse primers (10 μM), 0.2 μl of one Taq DNA polymerase
(5,000 U/ml) (New England Biolabs, Hertfordshire, UK), and 5 μl DNA template.
PCR was performed in a GeneAmp PCR system 9700 thermal cycler (AB Applied
Biosystems, Singapore) with programming conditions determined empirically.
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For qnrA, qnrB, qnrS, gyrA, blaSHV, blaCTX-M, and tetB, 35 cycles of initial
denaturation at 95 °C for 5 min, denaturation at 95 °C for 30 s, annealing at 60 °C
for 30 s, elongation at 72 °C for 1 min, and final elongation at 72 °C for 10 min
were used; whereas for blaTEM and tetA, PCR conditions were similar only with a
different annealing temperature of 56 °C. The negative control was water, whereas
positive controls include S. Typhimurium P5002212DT104 for gyrA, S. Virchou
58.67 Holland for blaCTX, S. Bredeney TEM-104 (Gisele) for blaTEM,
S. Keurmassar DAK2 for blaSHV, Enterobacter cloacae 03-577 for qnrA, Klebsi-
ella pneumoniae KP15 for qnrB, Escherichia coli pHC19 for qnrS,
E. coli NCTC50078 for tetA, and E. coli CSH50:TN10 for tetB. PCR products
were separated on a 1.5% agarose gel at 120 V and a 100-bp DNA ladder
(New England Biolabs) was used as molecular weight maker.
DNA sequencing
PCR amplification products were sent to a commercial facility (Eurofins
Genomics, France) for sequencing. Sequence results were analyzed and compared
with sequences in the GenBank using BLAST (https://blast.ncbi.nlm.nih.gov/
Blast.cgi) and CARD (https://card.mcmaster.ca/analyze/blast). Phylogenetic
analysis was performed using the MEGA 7.0 software [32].
Table I. Primers used in the detection of antibiotic resistance genes
Primer Sequence
Amplicon
size Reference
qnrA F: 5′-GGATGCCAGTTTCGAGGA-3′ 502 Cavaco et al. [24]
qnrA R: 5′-TGCCAGGCACAGATCTTG-3′
qnrB F: 5′-GGMATHGAAATTCGCCACTG-3′ 280 Cattoir et al. [25]
qnrB R: 5′-TTTGCYGYYCGCCAGTCGAA-3′
qnrS F: 5′-TCGACGTGCTAACTTGCG-3′ 480 Cavaco et al. [24]
qnrS R: 5′-GATCTAAACCGTCGAGTTCGG-3′
gyrA F: 5′-TACCGTCATAGTTATCCACGA-3′ 300 Wiuff et al. [26]
gyrA R: 5′-GTACTTTACGCCATGAACGT
blaTEM F: 5′-GCGGAACCCCTATTTG-3′ 970 Olesen et al. [27]
blaTEM R: 5′-ACCAATGCTTAATCAGTGAG-3′
blaCTX-M F: 5′-ATGTGCAGYACCAGTAARGTKATGGC-3′ 605 Hendriksen et al. [28]
blaCTX-M R: 5′-TGGGTRAARTARGTSACCAGAAYSAGCGG-3′
blaSHV F: 5′-TTATCTCCCTGTTAGCCACC-3′ 796 Arlet et al. [29]
blaSHV R: 5′-GATTTGCTGATTTCGCTCGG-3′
tetA F: 5′-GTAATTCTGAGCACTGTCGC-3′ 988 Waters et al. [30]
tetA R: 5′-CTGCCTGGACAACATTGCTT-3′
tetB F: 5′-CTC AGT ATT CCA AGC CTT TG-3′ 414 Sengeløv et al. [31]
tetB R: 5′-ACT CCC CTG AGC TTG AGG GG-3′
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Statistical analysis
Statistical analysis and graphics were performed using GraphPad Prism
software 5.01 (La Jolla, CA, USA) and Microsoft Excel (Microsoft Cooperation,
2013 USA). Statistical significance of proportions was assessed using the χ2 test
considering p< 0.05 as significant.
Results
Isolation and identification
A total of 71 Salmonella isolates were recovered from 664 stool samples
collected from humans, cattle, sheep, and chicken with a recovery rate of 10.7%.
Forty-eight percent of the isolates were obtained from chicken, whereas 22.5%
was from sheep (Table II). Forty-four different serovars were identified with
S. Budapest having the highest occurrence 31.8% (14/44) followed by S. Essen
15.9% (7/44) with S. Paratyphi C having the least with 4.5% (2/44) (Table III).
Antimicrobial susceptibility testing
Altogether 68% of all Salmonella isolates (n= 48) were susceptible to all 21
test antibiotics. The highest rates of resistance was found to nalidixic acid, (12/71;
16.9%) followed by ciprofloxacin 11.3%, while resistance to tetracycline and
minocycline was 9.9%. Thirty-one percent (n= 22) of the entire isolates exhibited
resistance to one or more of the test antibiotics, which was significant (p< 0.001)
compared to the susceptible isolates. Seven percent (n= 5) of the antibiotic
resistant isolates were MDR. Antibiotic resistance within population revealed
Table II. Distribution of the isolates from various sources and location
Site source
Number of stool samples collected
Number of Salmonella spp. isolated from
samples (%)
H S C CH Total H S C CH Total
Lagos Island 71 17 26 37 151 3 5 1 12 21
Mushin 76 0 0 18 94 2 0 0 5 7
Alabarago 55 22 68 7 152 2 2 9 6 19
Agege 74 47 8 22 151 2 8 1 8 19
Ikeja 49 0 0 0 49 1 0 0 0 1
Ikorodu 33 16 0 18 67 0 1 0 3 4
Total 358 102 102 102 664 10(14) 16(23) 11(15) 34(48) 71
Note: Sample source – H: human; S: sheep; C: cattle; CH: chicken.
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Table III. The occurrence of Salmonella serovars identified
CODE Antigenic formula Serotype Frequency of isolation
Isolates from chicken
A115/190 (1,3,19: z: I,w) S. Carno 1
CF10/191 (1,4,12,[27]: g,t: _) S. Budapest 13
F2/194
A152/198
E14/200
CF13/201
A6/202
CF3/206
F4/207
Fe/213
CF6/215
CF9/216
F5/219
AF13/220
B11y/196 (35: gst: _) S. Anecho 3
AF5/199
D10/204
E7/203 (3{10}{15}15,34:eh:1,5) S. Muenster 1
D8/209 (4,12:eh:1,7) S. Kaapstad 1
D6/205 (35: gt: _) S. Agodi 2
E15/211
A2/212 (8,20:Z4Z23:l,w) S. Dabou 1
A11/214 (4,[5],12:g,z51:e,n,z15) S. Tennyson 1
F12/217 (6,8:r:l,w) S. Goldcoast 1
AF1/218 (35:g,m,t:_) S. Ebrie 1
AF6/221 (4,12:g,m:_) S. Essen 3
E8/224
CF14/226
E6/222 (4,[5],12: l,v:e,n,z15) S. Brandenburg 1
E4/225 (3,10:f,g:e,n,x) S. Alfort 1
F1/227 (1,6,14,25:c:l,w) S. Minna 1
D3/193 (13,23:r:1,6) S. Linton 1
D25/210 (1,13,23:d:1,6) S. Wichita 1
D14/223 (35:g,m,s:_) S. Ealing 1
Total 34
Isolates from sheep
S59/230 (6,7,14:d:l,w) S. Livingstone 1
S63B/231 (6,7:d:1,6) S. Kivu 1
S43/232 (17:c:1,5) S. Berlin 1
S57/233 (4,12:g,m:_) S. Essen 4
S38B/235
S56/236
S81/247
S36C/237 (17:b:1,5) S. Dahra 2
S36/241
S37/240 (4,12:I,w:1,5) S. Mono 1
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that 43.8% (n= 7/16) of isolates from sheep showed resistance to one or more
antibiotics closely followed by isolates from humans with 40% (4/10) resistance.
Percentage of antibiotic resistance of Salmonella isolates from chicken was 29.4%
(10/34; Figure 1).
Detection of resistance genes by PCR
From PCR analysis, Salmonella isolates that displayed phenotypic
resistance to antibiotics were positive for some antibiotic resistance genes assayed
Table III. The occurrence of Salmonella serovars identified (Continued)
CODE Antigenic formula Serotype Frequency of isolation
S61/239 (1,4,12:z10:I,w) S. Mura 1
S28/242 (8,20:z10:e,n,z15) S. Chomedey 1
S38/243 (8,20:d:1,5) S. Yovokome 1
S43/244 (16:d:1,5) S. Sculcoates 1
S51/246 (1,4,12[27]:b:l,w) S. Wien 1
S76/234 (3{10}{15}{15,34}:y:1,5) S. Orion 1
Total 16
Isolates from cattle
CO18/249 (3,10:d:1,7) S. Onireke 1
CO67/248 (6,7:z4z24:_) S. Somone 1
CO20/251 (13,23:z:1,6) S. Farmsen 4
CO15/252
CO26/257
CO38/255
CO101/250 (28: z4z24:_) S. Ketheabarny 1
CO19/253 (1, 4,12[27]:gt:_) S. Budapest 1
CO37/254 (43,:g,z62:enx) II 1
CO50/256 (1,4,12,27:lz13z28:e,n,z15) S. Vom 1
CO12/258 (1,4,[5],12:eh:enz15) S. Sandiego 1
Total 11
Isolates from human
H132/266 (1,4,12,[27]:b:1,5) S. Limete 1
H44/267 (9,12:z10:1,5) S. Portland 1
H45/268 (1,4,12:a:I,w) S. Huettwillen 1
H63/269 (6,8:z:1,5) S. Mowanjum 1
HL8/263 (6,7[vi]:c:1,5) S. Paratyphi C 2
H418/274
H363/271 (1,4,12,27:i:1,2) S. Tyhpimurium 1
H209/272 (6,8:i:1,5) S. Takoradi 1
H183/273 (1,4[5],12:b:1,2) S. Paratyphi B 1
H117/275 (1,13,23:a:1,5) S. Chagoua 1
Total 10
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(Table IV). qnrB gene was detected in 10 (45.4%) of the isolates and qnrS was
detected in 1 isolate (Figures 2 and 3). blaCTX, blaSHV, and qnrAwere not detected
in any of the isolates; however, 22.7% (5/22) was positive for blaTEMtetA was also
detected in 18.1% (4/22) of the isolates. The gyrA sequences of 12 isolates
(GenBank accession numbers: MG593259–MG593270) were grouped into four
clades with S. Typhimurium largely diverged. S. Budapest isolated from cattle and
S. Budapest isolated from chicken were close, whereas S. Essen from sheep and
chicken was grouped together in a clade, indicating evolutionary relatedness.
Some isolates were grouped alongside S. Typhimurium (accession numbers:
X78977 and EU512997) from GenBank (Figure 4).
Discussion
Diversity and gene variation among antibiotic-resistant S. enterica serovars
of food animal sources continues to expand. Of the 71 Salmonella isolates from
human, cattle, sheep, and chicken, 44 serovars were obtained with isolates from
chicken accounting for 17 of these serovars. This is not surprising as poultry has
been known to be a major reservoir and vehicle of transmission of S. serovars to
humans [33]. S. Budapest had the highest rate of occurrence in poultry from
different locations sampled. Although this serovar has not been reported in any
AMP CEF NAL SXT NXN CIP TET MNO GEN AMC CHL CST
0
2
4
6
8
10
Human
Chicken
Sheep
Cattle
Antibiotic
N
u
m
b
er
 o
f 
R
es
is
ta
n
t 
Is
o
la
te
s
Figure 1. Distribution of resistance to antibiotics among Salmonella isolates from human, chicken,
sheep and cattle. AMP: ampicillin; CEF: cephalotin; NAL: nalidixic acid; SXT: trimethoprim/
sufamethoxazole; NXN: norfloxacine; CIP: ciprofloxacin; TET: tetracycline; MNO: minocycline;
GEN: gentamycin
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Table IV. Antimicrobial resistance phenotype, and genes of Salmonella serovars isolated from humans,
chicken, sheep, and cattle
Code Origin Phenotype Genes Serotype
F5/219 Chicken NAL, NXN, and CIP gyrA and qnrB S. Budapest
CF3/206 Chicken NAL gyrA and qnrB S. Budapest
Fe/213 Chicken NAL, NXN, and CIP gyrA and qnrB S. Budapest
A152/198 Chicken NAL qnrB S. Budapest
A115/190 Chicken NAL gyrA S. Carno
D6/205 Chicken NAL, NXN, and CIP gyrA and qnrB S. Agodi
A11/214 Chicken NAL, gyrA and qnrB S. Tennyson
AF6/221 Chicken NAL, NXN, and CIP gyrA and qnrB S. Essen
A2/212 Chicken TET and MNO qnrB, qnrS, and TetA S. Dabou
E14/200 Chicken GMI – S. Budapest
CO19/253 Cattle TET and MNO TetA S. Budapest
H117/275 Human AM, NAL, SXT, NXN, and CIP gyrA and TetA S. Chagoua
H63/269 Human AM and CEF – S. Mowanjum
H44/267 Human AM and CEF – S. Portland
H363/271 Human AM and CEF – S. Typhimurium
S57/233 Sheep AM and TET blaTEM and TetA S. Essen
S38B/235 Sheep AM, TET, and SXT blaTEM S. Essen
S56/236 Sheep NAL, NXN, and CIP gyrA and qnrB S. Essen
S81/247 Sheep MNO and TET blaTEM S. Essen
S61/239 Sheep NAL, NXN, and CIP gyrA S. Mura
S28/242 Sheep NAL, TET, SXT, NXN, and CIP qnrB and blaTEM S. Chomedey
S51/246 Sheep MNO and TET blaTEM S. Wien
Figure 2.Agarose gel image of PCR products showing positive bands for qnrB. Lane 1 –M: 100-bp
DNA marker, lane 2 – PC: positive control Klebsiella pneumonia KP15, lane 19 – NC: negative
control, 1- S. Carno, 6, 8, 14, 20, 26- S. Budapest, 13- S. Agodi, 19- S. Dabou, 21- S. Tennyson, and
28- S. Essen
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human outbreak in Nigeria, a 2016 Salmonella annual report of the Centers for
Disease Control and Prevention USA reported S. Budapest isolated from at least
one patient with enteric fever in the USA between 2003 and 2013 [34].
NTS serovars accounted for majority of S. serovars from all three food animals
Figure 3. Agarose gel image of PCR products showing positive bands for qnrS. Lane 1 –M: 100-bp
DNA marker, lane 2 – PC: positive control Escherichia coli pHC19, lane 16 – NC: negative control,
19- S. Dabou
Figure 4. gyrA phylogenetic tree constructed based on an alignment of gyrA sequences of 12 isolates
from human, chicken, cattle, and sheep with gyrA gene of Salmonella Typhimurium (EU512997 and
X78977) from GenBank
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(cattle, sheep, and chicken). NTS serovars have a vast host range including
ruminants and birds with their products (eggs, meat, and milk) acting as vehicle for
the transmission of Salmonella infections to humans and have been implicated in
bacterial bloodstream infections in children and adults in sub-Saharan
Africa [35–37]. Rare serovars were present in chicken, which included S. Alfort,
S. Wichita, S. Linton, S. Ealing, and S. Ebrie. In a similar study, Smith et al. [6]
reported the occurrence of rare serovars including S. Amoutive, S. Ealing,
S. Urbana, S. Bargny, S. Drac, and S. Nyborg in beef, chicken, goat, and pork
sold in different markets in Lagos Nigeria. Food animals remain a major source of
diverse serovars of Salmonella. This study reports the first isolation of rare
serovars S. Mowanjum, S. Huettwillen, S. Limete, and S. Chagoua from apparently
healthy humans in Nigeria. Although these serovars have been isolated from
animals, animal products, and animal feeds in Denmark and Thailand, respectively
[38, 39]. This finding is of public health relevance because these individuals who
are food handlers are likely to disseminate the bacteria, since Salmonella has the
tendency of persisting in macrophages and other immune cells coupled with
chronic carrier status, which entails excreting the bacteria for some time that may
be the case in this study [40]. No same serovar was recovered from human and
animal sources, which indicates the difficulty in establishing the route of trans-
mission of Salmonella serovars within the food chain. However, one isolate of
S. Budapest was isolated from cattle and isolates of S. Essen were recovered from
both chicken and sheep. Salmonella serovars displayed varied antibiotic suscep-
tibility pattern with 16.9% resistance to nalidixic acid and 11.3% resistance to
ciprofloxacin and norfloxacin. Most of these resistances to tested quinolone and
fluoroquinolones were observed in isolates from chicken and sheep, which
corroborates the findings of Raufu et al. [41] who reported a high-level resistance
of Salmonella isolates of poultry origin to ciprofloxacin and nalidixic acid in the
northern–eastern region of Nigeria. Zhu et al. [42] also reported a very high rate of
resistance to nalidixic acid (99.5%) and ciprofloxacin (43%) in Salmonella isolates
of poultry origin in China. This indicates a high use of quinolones in both human
and veterinary medicine. Some isolates phenotypically exhibited resistance to
some of the test antibiotics with no concomitant detection of resistance genes
responsible for such resistance. This was observed in both human and animal
isolates, for example S. Mowanjum, S. Portland, and S. Typhimurium were
resistant to ampicillin and cephalotin yet no beta-lactamase (bla) genes were
detected. In addition, S. Wien isolated from sheep was resistant to tetracycline but
no tetA nor tetB genes were detected. Conversely, S. Chagoua, S. Essen, and S.
Wien possessed the resistance genes but resistance phenotype was not observed.
Similar observation was made by Afzal et al. [43] who reported S. Typhi isolates
that were resistant to ampicillin and tetracycline with no detected corresponding
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resistance genes. In the opinion of previous study of Adesiji et al. [44], such
phenomenon may be due to non-expression of the genes responsible referred to as
silent gene. qnr genes that indicates plasmid-mediated resistance of quinolones
and fluoroquinolones were detected. Among antibiotic-resistant serovars, 43%
were positive for qnrB gene with only one S. Dabou having qnrS in addition to
qnrB; however, this isolate did not exhibit any phenotypic resistance to nalidixic
acid nor ciprofloxacin. In a previous study, Fashae and Hendriksen [45] reported
the detection of qnrB19 in S. Corvallis and qnrS1 in S. Derby isolated from pig
farms in Ibadan, Nigeria. In this study, presumed mutations in gyrA gene would
have resulted in ciprofloxacin resistance exhibited by serovars in which qnr genes
were not detected, since mutation in gyrA gene resulting in ciprofloxacin resistance
is widespread in Africa [46]. According to Baker et al. [47], selective and
sustained pressure is the driving force for the evolution of antimicrobial resistance.
Evolutionary analysis of gyrA genes in this study showed that gyrA gene in
S. enterica from both human and food animals exhibits variations but are
evolutionarily interconnected. Three major clades and a single largely diverged
lineage were observed from the phylogenetic relationship analysis of isolates from
both human and food animals using sequences of gyrA genes. The major clade had
five Salmonella serovars from human (S. Paratyphi C) and chicken (S. Budapest
and S. Agodi) clustering with X789771.1 S. Typhimurium serovar from the
GenBank (NCBI), which was isolated from infected human subjects in the United
Kingdom with a presumed zoonotic source: including chicken, turkey, eggs litter
and imported exotic birds [48]. The second clade comprised S. Essen (g28) from
chicken, S. Essen (g38) from sheep, and S. Tennyson (g21) from chicken, which
was close to reference strain EU512997.1 S. Typhimurium from the GenBank,
which was isolated from patients in Korea. Hence, a clonal expansion has been
indicated by Chattaway et al. [49] who reported the difficulty in discerning clonal
origin and distinguishing clonal expansion from evolutionary convergence of
clonal lineages of fluoroquinolone-resistant S. Typhimurium DT104 and
S. Kentucky. In this study, all blaTEM genes detected were from isolates of sheep
origin and belong to the TEM-144, TEM-135, and TEM-4 variants. This points to
the fact that contaminated mutton could also be a potential source of beta-
lactamase genes. Little or no attention has been paid to this food animal in terms
of being a reservoir of antibiotic-resistant Salmonella serovars even when
largely consumed in Nigeria. In this study, there was no resistance to third
and fourth generation cephalosporins; however, utmost caution should be
observed since dependency on this group of antibiotics in treatment most
especially of children is high [37]. Thus, the need for prudent use of these
drugs in both veterinary and human medicine is advocated to prevent the
development of resistance.
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Food-borne Salmonella serovars remains a public health risk; hence, there
is a need for continuous antimicrobial resistance surveillance and monitoring in
food animals and humans. Antibiotic surveillance systems is generally lacking
in Africa. Thus, the results from this study can serve as a template for broader
and further studies to provide a comprehensive data that can be used for
formulating policies for antibiotics regulation in human and animal medicine to
prevent and control outbreaks of multidrug resistance in food animals and
humans.
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